These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2542629)

  • 1. The importance of presynaptic beta receptors in Raynaud's disease.
    Brotzu G; Falchi S; Mannu B; Montisci R; Petruzzo P; Staico R
    J Vasc Surg; 1989 Jun; 9(6):767-71. PubMed ID: 2542629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of presynaptic beta-receptors in Raynaud's disease.
    Brotzu G; Carboni MG; Falchi S; Montisci R; Petruzzo P
    Artery; 1985; 13(2):77-86. PubMed ID: 3002305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raynaud's phenomenon and calcium blocking agents. A preliminary open study with flunarizine].
    Centonze V; Campanale G; Vino M; Caporaletti P; Magrone D; Russo P; Di Bari M; Loragno V; Albano O
    Clin Ter; 1991 Apr; 137(2):77-82. PubMed ID: 1828407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Raynaud's syndrome among haemodialyzed patients: influence of flunarizine treatment.
    Bellinghieri G; Savica V; De Gregorio C; De Gregorio G; Consolo F
    Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):163-5. PubMed ID: 1830409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A; McCans J; Willan AR; Ford PM
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB; Guseva NG; Mach ES
    Ter Arkh; 1987; 59(4):89-92. PubMed ID: 3296288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
    Sarkozi J; Bookman AA; Mahon W; Ramsay C; Detsky AS; Keystone EC
    J Rheumatol; 1986 Apr; 13(2):331-6. PubMed ID: 3723496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists for the treatment of Raynaud's phenomenon].
    Müller-Bühl U; Diehm C; Scheuermann W; Mörl H
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1795-7. PubMed ID: 6357692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow release nifedipine in the treatment of Raynaud's phenomenon.
    Costantini A; Martelli E; Bavera P; Agus GB
    Int Angiol; 1987; 6(4):359-63. PubMed ID: 3330116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers: a new therapeutic approach to Raynaud's disease.
    Brotzu G; Susanna F; Roberto M; Palmina P
    Microvasc Res; 1987 Mar; 33(2):283-8. PubMed ID: 2884554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered regulator mechanisms of presynaptic adrenergic nerve: a new physiopathological hypothesis in Raynaud's disease.
    Giovanni B; Giuseppina CM; Susanna F; Roberto M
    Microvasc Res; 1984 Jan; 27(1):110-3. PubMed ID: 6323930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of ketanserin and pentoxiphylline in treatment of Raynaud's phenomenon.
    Arosio E; Montesi G; Zannoni M; Paluani F; Lechi A
    Angiology; 1989 Jul; 40(7):633-8. PubMed ID: 2662829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isosorbide dinitrate ointment in Raynaud's disease.
    Diehm C; Müller-Bühl U; Mörl H
    Z Kardiol; 1983; 72 Suppl 3():185-7. PubMed ID: 6364591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
    J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome.
    Csiki Z; Garai I; Shemirani AH; Papp G; Zsori KS; Andras C; Zeher M
    Microvasc Res; 2011 Jul; 82(1):84-7. PubMed ID: 21515290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.